Show simple item record

dc.contributor.authorNatukunda, B.
dc.contributor.authorMugyenyi, G.
dc.contributor.authorBrand, A.
dc.contributor.authorSchonewille, H.
dc.date.accessioned2022-01-24T19:07:36Z
dc.date.available2022-01-24T19:07:36Z
dc.date.issued2011
dc.identifier.citationNatukunda, B., Mugyenyi, G., Brand, A., & Schonewille, H. (2011). Maternal red blood cell alloimmunisation in south western Uganda. Transfusion Medicine, 21(4), 262-266.https://doi.org/10.1111/j.1365-3148.2011.01073.xen_US
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/1514
dc.description.abstractTo identify the frequency and nature of maternal red blood cell (RBC) alloimmunisation in Uganda and to determine the prevalence of RhD negativity and the rate of RBC alloimmunisation in Ugandan pregnant women.Haemolytic disease of the foetus and newborn (HDFN) results from maternal alloimmunisation following exposure to allogeneic RBCs during pregnancy or blood transfusion. The prevalence of maternal RBC alloimmunisation in Ugandans is not known. Pregnant women at Mbarara Hospital, South Western Uganda, were investigated in a cross-sectional study. Demographics, transfusion and obstetric histories were recorded. Maternal RBC alloimmunisation was demonstrated using immunohaematological techniques. A total of 2001 pregnant women were recruited; 3·6% of them being RhD negative. Forty-five women (2·2%; 95% CI: 1·6–2·9) were found to be alloimmunised to RBC antigens. There were 38 RBC alloantibodies of known specificity including anti-S, 12; anti-M, 11; anti-Lea, 6; anti-D, 4 and 1 each of anti-K, anti-Fyb, anti-Jka, anti-Lua and anti-Kpa. In two women (4·4%), there were antibody combinations (anti-M+S and anti-K+Kpa). Obstetric history, gestational age and previous immunising events were not significantly associated with the rate of alloimmunisation.This study revealed a maternal RBC alloimmunisation rate of 2·2% which was comparable with findings from a Zimbabwean study where the prevalence was 1·7%. Given the 6·0% prevalence of anti-D among RhD-negative women in our study and the high immunogenicity of the D antigen, programmes for preventing anti-D alloimmunisation and HDFN in Uganda should be considered seriously.en_US
dc.language.isoenen_US
dc.publisherTransfusion Medicineen_US
dc.subjecthaemolytic disease of the newborn, maternal alloimmunisation, pregnancy, RBC alloantibodies, Uganda.en_US
dc.titleMaternal Red Blood Cell Alloimmunisation In South Western Ugandaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record